chemotherapy - search results

NHS cancer patients will be the first to experience drone chemotherapy, which furthers the NHS net zero strategy, as it cuts down travel time and distance.

Damaged heart muscle is a tragic possibility for patients of breast cancer chemotherapy - but thanks to Dr Husam Abdel-Qadir, there may now be a way to stop it.

Boston Medical Center researchers found that Black individuals, above all other racial groups, are less likely to receive lung cancer chemotherapy.

Scientists have determined a new way to protect the hair follicle from chemotherapy in an effort to prevent hair loss as a result of cancer treatments.

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment, as Emma Saxon reveals in this article

Nanotextures on nanoparticles and implants to kill cancer cells in a more targeted manner may just be the key to tackling resistance to traditional cancer drugs.

Peter J. Houghton from Greehey Children’s Cancer Research Institute and Mary-Ann Bjornsti from the University of Alabama discuss some of the key challenges in the development of therapies for pediatric cancer care.

Using artificial intelligence, scientists have tackled one of the toughest challenges in cancer research.

Starting in January 2020, the European REVERT project is now in its final phase. The project blends predictive medicine and AI to enable clinicians to quickly and adequately treat patients.

Current oncology treatments have significantly improved cancer survival rates, but more effective and safer therapeutics are needed.

Simon Holt, Honorary Professor at Swansea University, reflects on the key challenges within cancer care and the benefits of genomic testing in improving patient outcomes.

NHS trusts are exploring new opportunities to use infrastructure that they already own. The aim? To better engage with patients, alleviate their anxieties, and inform patients what is happening regarding their care, whilst at the same time reducing pressures on busy wards. Matt O’Donovan, Chief Executive at SPARK TSL, explains.

Professor Peter J. Houghton from the Greehey Children’s Cancer Research Institute discusses new approaches to pediatric cancer treatment specifically for BRAF-mutant pediatric glioma.

Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, explores the key challenges in mesothelioma prevention, diagnosis and treatment.

UK-based charity, Epilepsy Action, outlines how glioma-related epilepsy can heavily impact a person’s quality of life, drawing on the need for further research and treatment options.

RESCUER is an EU Horizon 2020 project, coordinated by the University of Oslo, Norway, that aims to predict treatment response and test new combinational therapies for complex breast cancer subtypes.

With current strategies proving inadequate, what needs to be done is to further the research into detecting, treating, and controlling ovarian cancer.

Professor Mark Cunningham and Dr Kate Connor from Trinity College Dublin discuss the burden of brain tumour-related epilepsy and why novel therapies are urgently needed to improve the quality of life for those affected.

Considering the high, unmet medical need associated with peritoneal metastases, Dr Dominic Griffiths, CEO of Alesi Surgical Ltd, outlines how the company’s innovative Ultravision technology could dramatically improve clinical outcomes for patients with the disease.

Bryn Sage, CEO of Inhealthcare, provides a detailed and optimistic view of remote monitoring technology for the future of our health service.